Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

Overview of attention for article published in Malaria Journal, July 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 26,559 followers.

Policy changes to #malaria drug, DP, reduces adverse maternal+pregnancy outcomes http://t.co/O6agZOLmwP @ricprice99 @MenziesResearch

Policy changes to #malaria drug, DP, reduces adverse maternal+pregnancy outcomes http://t.co/O6agZOLmwP @ricprice99 @MenziesResearch

Policy changes to #malaria drug, DP, reduces adverse maternal+pregnancy outcomes http://t.co/O6agZOLmwP @ricprice99 @MenziesResearch

Policy changes to #malaria drug, DP, reduces adverse maternal+pregnancy outcomes http://t.co/O6agZOLmwP @ricprice99 @MenziesResearch

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.